A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors (Q44931522)

7 December 2017

title

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors (English)

1 reference

7 December 2017

1

Michael P Busch

1 reference

7 December 2017

3

Susan L Stramer

1 reference

7 December 2017

2

Simone A Glynn

1 reference

7 December 2017

5

Sally Caglioti

1 reference

7 December 2017

7

Brandee Pappalardo

1 reference

7 December 2017

D Michael Strong

4

1 reference

7 December 2017

David J Wright

series ordinal

6

1 reference

7 December 2017

Steven H Kleinman

series ordinal

8

1 reference

7 December 2017

NHLBI-REDS NAT Study Group

series ordinal

9

1 reference

7 December 2017

publication date

1 February 2005

1 reference

7 December 2017

1 reference

7 December 2017

volume

45

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

254-264

1 reference

Current and emerging infectious risks of blood transfusions

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

International application of the incidence rate/window period model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Results of viral marker screening of unpaid blood donations and probability of window period donations in 1997. EPFA Working Group on Quality Assurance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Use of laboratory tests and clinical symptoms for identification of primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

HIV seroconverting donors delay their return: screening test implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Antigen testing for human immunodeficiency virus (HIV) and the magnet effect: will the benefit of a new HIV test be offset by the numbers of higher risk, test-seeking donors attracted to blood centers? Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

NAT of the United States and Canadian blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Nucleic acid amplification technology methods used in blood donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Immune response to blood transfusion invery-low-birthweight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Human immunodeficiency virus type 1-infected blood donors: behavioral characteristics and reasons for donation. The HIV Blood Donor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

First report of human immunodeficiency virus transmission via an RNA-screened blood donation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Fluctuation of HCV viral load before seroconversion in a healthy volunteer blood donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Validating marker-based incidence estimates in repeatedly screened populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2004.04215.X

10.1111/J.1537-2995.2004.04215.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference